More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/MediaLibrary/Images/2025-07-02-11-33-24-371-686519042730a92ea84dd440.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-01-24-17-19-59-853-6974ff3f8a71e5f81a351f11.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-01-13-10-12-19-818-69661a83966611ff708d02e0.jpg)